+検索条件
-Structure paper
タイトル | Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. |
---|---|
ジャーナル・号・ページ | Nat Struct Mol Biol, Vol. 28, Issue 9, Page 740-746, Year 2021 |
掲載日 | 2021年8月11日 |
著者 | Florian Kabinger / Carina Stiller / Jana Schmitzová / Christian Dienemann / Goran Kokic / Hauke S Hillen / Claudia Höbartner / Patrick Cramer / |
PubMed 要旨 | Molnupiravir is an orally available antiviral drug candidate currently in phase III trials for the treatment of patients with COVID-19. Molnupiravir increases the frequency of viral RNA mutations and ...Molnupiravir is an orally available antiviral drug candidate currently in phase III trials for the treatment of patients with COVID-19. Molnupiravir increases the frequency of viral RNA mutations and impairs SARS-CoV-2 replication in animal models and in humans. Here, we establish the molecular mechanisms underlying molnupiravir-induced RNA mutagenesis by the viral RNA-dependent RNA polymerase (RdRp). Biochemical assays show that the RdRp uses the active form of molnupiravir, β-D-N-hydroxycytidine (NHC) triphosphate, as a substrate instead of cytidine triphosphate or uridine triphosphate. When the RdRp uses the resulting RNA as a template, NHC directs incorporation of either G or A, leading to mutated RNA products. Structural analysis of RdRp-RNA complexes that contain mutagenesis products shows that NHC can form stable base pairs with either G or A in the RdRp active center, explaining how the polymerase escapes proofreading and synthesizes mutated RNA. This two-step mutagenesis mechanism probably applies to various viral polymerases and can explain the broad-spectrum antiviral activity of molnupiravir. |
リンク | Nat Struct Mol Biol / PubMed:34381216 / PubMed Central |
手法 | EM (単粒子) |
解像度 | 3.2 - 3.3 Å |
構造データ | EMDB-13135, PDB-7ozu: EMDB-13138, PDB-7ozv: |
化合物 | ChemComp-ZN: |
由来 |
|
キーワード | VIRAL PROTEIN / SARS-CoV-2 / RNA-dependent RNA polymerase / Molnupiravir (NHC) |